Company Analysis

Jasper Therapeutics, Inc. (JSPR)

Nasdaq: JSPR · Biological Products, (No Diagnostic Substances) · Redwood City, CA · filing with the SEC since 2019
Grade4.1
◀ Past 2.9● Present 2.5▶ Future 6.2
6 est.

Who runs Jasper Therapeutics, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Mahal Jeetinder Singh
CEO and President. First filing Oct 2021, latest Feb 10, 2026, 5 filings in all.
Officers reporting now
7
of 14 people with a filing in the last fifteen months
Directors reporting now
7
26 people on the record since 2019
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Keenan GregChief Medical OfficerJul 2026Jul 23, 2026none
Ros Matthew EChief Operating OfficerJul 2026Jul 22, 2026none
Song WenruEVP, Head of R&DJul 2026Jul 22, 2026none
Mahal Jeetinder SinghCEO and PresidentOct 2021Feb 10, 2026none
Martell RonPresident, CEO and DirectorMar 2022Jan 5, 2026none
Cross HerbChief Financial OfficerSep 2023Jan 5, 2026none
Kapoor VishalPresidentJan 2020Jul 3, 2025none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Crutcher Patrick JdirectorJul 2026Aug 4, 2026none
Emster Kurt VondirectorOct 2021Aug 4, 2026none
Lucas SvetlanadirectorJun 2024Aug 4, 2026none
Shizuru Judith AnnedirectorOct 2021Aug 4, 2026none
Wiggans Thomas GdirectorNov 2023Aug 4, 2026none
Brun Scott C.directorJun 2023Jul 3, 2025none
Nolet ChrisdirectorOct 2021Jul 3, 2025none
Earlier names on the record32, newest filing first
Tucker Edwin Jonathan · officer · last filing Jun 2025French Anna Louise · director · last filing Jun 2024Abingworth Bioventures Vii LP · 10% owner · last filing Feb 2024Abingworth Llp · 10% owner · last filing Feb 2024Carlyle Genesis Uk LLC · 10% owner · last filing Feb 2024Carlyle Group Inc. · 10% owner · last filing Feb 2024Carlyle Holdings I Gp Inc. · 10% owner · last filing Feb 2024Carlyle Holdings I Gp Sub L.L.C. · 10% owner · last filing Feb 2024Carlyle Holdings I L.P. · 10% owner · last filing Feb 2024Carlyle Investment Management LLC · 10% owner · last filing Feb 2024Cg Subsidiary Holdings L.L.C. · 10% owner · last filing Feb 2024Tc Group, LLC · 10% owner · last filing Feb 2024Venkataraman Balaji · officer · last filing Feb 2024Avego Healthcare Capital Holdings, LLC · other · last filing Feb 2024Avego Healthcare Capital, L.P. · other · last filing Feb 2024Avego Management LLC · other · last filing Feb 2024Morgan Adam · 10% owner · last filing Feb 2024Velan Capital Holdings LLC · other · last filing Feb 2024Velan Capital Investment Management LP · 10% owner · last filing Feb 2024Velan Capital Management LLC · 10% owner · last filing Feb 2024Velan Capital Master Fund LP · other · last filing Feb 2024Lis William · officer · last filing Oct 2023Klein Lawrence Otto · director · last filing Jun 2023Mcdade Mark · 10% owner · last filing Apr 2023Qiming U.S. Healthcare Fund II, L.P. · 10% owner · last filing Apr 2023Heller Kevin N. · officer · last filing Mar 2022Clifford Kenneth F · officer · last filing Sep 2021Hoffen Howard I · director · last filing Sep 2021Dolan Peter R · director · last filing Nov 2019Eshelman Fredric N · director · last filing Nov 2019Mario Ernest · director · last filing Nov 2019Reicin Glenn · director · last filing Nov 2019

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton JSPR · research, not advice